Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/60053
Type
ArticleCopyright
Restricted access
Embargo date
3100-12-31
Collections
Metadata
Show full item record
ORGANOGOLD(III)-DITHIOCARBAMATE COMPOUNDS AND THEIR COORDINATION ANALOGUES AS ANTI-TUMOR AND ANTI-LEISHMANIAL METALLODRUGS
Author
Affilliation
Universidade Federal de Minas Gerais. Departamento de Química. Laboratório de Síntese e Interações Bioinorgânicas. Belo Horizonte, MG, Brazil/Chair of Medicinal and Bioinorganic Chemistry. Department of Chemistry. Technical University of Munich. Garching b. Munich, Germany.
Fundação Oswaldo Cruz. Instituto René Rachou. Biotecnologia Aplicada ao Estudo de Patógenos. Belo Horizonte, MG, Brazil.
Chair of Medicinal and Bioinorganic Chemistry. Department of Chemistry. Technical University of Munich. Garching b. Munich, Germany.
Universidade Federal de Minas Gerais. Departamento de Química. Laboratório de Síntese e Interações Bioinorgânicas. Belo Horizonte, MG, Brazil
Universidade Federal do Piaui. Departamento de Bioquímica e Farmacologia. Teresina, PI, Brazil.
Chair of Medicinal and Bioinorganic Chemistry. Department of Chemistry. Technical University of Munich. Garching b. Munich, Germany.
Fundação Oswaldo Cruz. Instituto René Rachou. Biotecnologia Aplicada ao Estudo de Patógenos. Belo Horizonte, MG, Brazil.
Universidade Federal de Minas Gerais. Departamento de Química. Laboratório de Síntese e Interações Bioinorgânicas. Belo Horizonte, MG, Brazil
Fundação Oswaldo Cruz. Instituto René Rachou. Biotecnologia Aplicada ao Estudo de Patógenos. Belo Horizonte, MG, Brazil.
Chair of Medicinal and Bioinorganic Chemistry. Department of Chemistry. Technical University of Munich. Garching b. Munich, Germany.
Universidade Federal de Minas Gerais. Departamento de Química. Laboratório de Síntese e Interações Bioinorgânicas. Belo Horizonte, MG, Brazil
Universidade Federal do Piaui. Departamento de Bioquímica e Farmacologia. Teresina, PI, Brazil.
Chair of Medicinal and Bioinorganic Chemistry. Department of Chemistry. Technical University of Munich. Garching b. Munich, Germany.
Fundação Oswaldo Cruz. Instituto René Rachou. Biotecnologia Aplicada ao Estudo de Patógenos. Belo Horizonte, MG, Brazil.
Universidade Federal de Minas Gerais. Departamento de Química. Laboratório de Síntese e Interações Bioinorgânicas. Belo Horizonte, MG, Brazil
Abstract
The limited chemical stability of gold(III)-based compounds in physiological environment has been a challenge in drug discovery, and organometallic chemistry might provide the solution to overcome this issue. In this work, four novel cationic organogold(III)-dithiocarbamate complexes of general structure [(C^N)AuIIIDTC]PF6 (C1a - C4a, DTC = dithiocarbamate, L1 - L4, C^N = 2-anilinopyridine) are presented, and compared to their coordination gold(III)-dithiocarbamate analogues [AuIIIDTCCl2] (C1b - C4b), as potential anti-cancer and anti-leishmanial drugs. Most of the complexes effectively inhibited cancer cell growth, notably C3a presented anti-proliferative effect in the nanomolar range against breast cancer (MCF-7 and MDA-MB-231 cells with moderate selectivity. Pro-apoptotic studies on treated MCF-7 cells showed a high population of cells in early apoptosis. Reactivity studies of C3a towards model thiols (N-acetyl-L-cysteine) refer to a possible mode of action involving bonding between the organogold(III)-core and the thiolate. In the scope of neglected diseases, gold complexes are emerging as promising therapeutic alternatives against leishmaniasis. In this regard, all gold(III)-dithiocarbamate complexes presented anti-leishmanial activity against at least one Leishmania species. Complexes C1a, C4a, C1b, C4b were active against all tested parasites with IC50 values varying between 0.12 and 42 μM, and, overall, organometallic compounds presented more intriguing inhibition profiles. For C4a selectivity over 500-fold for L. braziliensis; even higher than the reference anti-leishmanial drug amphotericin B. Overall, our findings revealed that the organogold(III) moiety significantly amplified the anti-cancer and anti-leishmanial effects with respect to the coordination analogues; thus, showing the great potential of organometallic chemistry in metallodrug-based chemotherapy for cancer and leishmaniasis.
Share